Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-77.85	87.80	396.46
Graham Fair Price	-54.39	3356.41	7358.37
PEG	3154.94	0.36	0.01
Price/Book	-12.07	0.35	0.39
Price/Cash Flow	18.45	-4.81	-5.89
Prices/Earnings	-316.37	-28.75	-6.90
Price/Sales	8.06	0.33	0.30
Price/FCF	18.45	-4.81	-5.89
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-15.88	0.04	0.04
Operating Margin	20.73	< 0.005	< 0.005
ROA	79.20	< 0.005	< 0.005
ROE	-0.01	< 0.005	78.88
ROIC	< 0.005	< 0.005	646.01
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.09	0.14	-33.07
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.26	1.98	56.27
EPS QOQ	-6.18	0.79	-87.21
FCF QOQ	0.64	-0.07	-89.02
Revenue QOQ	0.18	-0.19	7.13
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	36.13	43.25	19.70
Days Sales Outstanding (DSO)	95.10	126.08	32.59
Inventory Turnover	2.49	2.08	-16.46
Debt/Capitalization	0.39	0.37	-5.82
Quick Ratio	0.88	0.81	-7.95
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13005.75	12908.89	-0.74
Cash	4622.54	3165.13	-31.53
Capex	-11.49	-1.44	87.46
Free Cash Flow	-866.86	-927.75	-7.02
Revenue	16919.83	13665.55	-19.23
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.24	1.17	-5.90
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	180.00	45.98	-74.46
Naive Interpretation	Member

06 - Financial Health · Bad

Rating